Suppr超能文献

与毛细胞白血病相关的副肿瘤性血管炎。

Paraneoplastic vasculitis associated with hairy cell leukemia.

作者信息

Svecová D, Pallová A, Chmurová N, Babal P

机构信息

Comenius University in Bratislava, Faculty of Medicine, Department of Dermatovenerology, Bratislava, Slovak Republic.

出版信息

Prague Med Rep. 2008;109(1):83-7.

Abstract

Hairy cell leukemia (HCL) is a rare B-cell lymphoproliferative disease, accounting for about 2-3% of all leukemias in adults. The skin lesions were described in about 10-12% of patients. Vasculitis in lymphoproliferative disease is relatively uncommon and may predate the diagnosis of lymphoproliferative disease. A 54-year old female with one month history of general symptoms and sudden onset of maculopapular exanthema on the skin, suffered from anemia, leukopenia and thrombocytopenia. Examination of the skin biopsy revealed lymphocytic vasculitis. Immunophenotyping of the skin biopsy revealed cell population with CD45RO, and small groups with CD20, partly DBA44 positivity. Bone marrow trepanobiopsy showed 50% infiltration with medium-sized lymphoid cells with clear cytoplasm and immunophenotypic coexpression of CD20 and DBA-44 antigens. The diagnosis of HCL was confirmed by flow cytometry of the bone marrow and of the peripheral blood cells that revealed pathological cell population with expression of CD11c, CD19, CD25, CD103. The patient was successfully treated with a single dose of cladribrine. The patient with acute vasculitis should be screened and monitored for possible lymphoproliferative diseases. Skin manifestation of acute vasculitis accompanied with hairy cells may be the first manifestation of HCL. Purine nucleoside analogue cladribrine is considered as the first line of therapy for HCL and induces a total response in more than 80% of cases with HCL.

摘要

毛细胞白血病(HCL)是一种罕见的B细胞淋巴增殖性疾病,约占成人白血病的2%-3%。约10%-12%的患者有皮肤病变的描述。淋巴增殖性疾病中的血管炎相对少见,可能在淋巴增殖性疾病诊断之前出现。一名54岁女性,有一个月的全身症状病史,皮肤突然出现斑丘疹,伴有贫血、白细胞减少和血小板减少。皮肤活检检查显示淋巴细胞性血管炎。皮肤活检的免疫表型分析显示细胞群表达CD45RO,小群细胞表达CD20,部分呈DBA44阳性。骨髓环钻活检显示50%的浸润为中等大小的淋巴细胞,细胞质清晰,免疫表型共表达CD20和DBA-44抗原。通过对骨髓和外周血细胞的流式细胞术检查确诊为HCL,结果显示病理性细胞群表达CD11c、CD19、CD25、CD103。该患者接受单剂量克拉屈滨治疗成功。对于急性血管炎患者,应筛查并监测是否可能患有淋巴增殖性疾病。伴有毛细胞的急性血管炎的皮肤表现可能是HCL的首发表现。嘌呤核苷类似物克拉屈滨被认为是HCL的一线治疗药物,在超过80%的HCL病例中可诱导完全缓解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验